Filipino-Americans: Vitamin D binding protein in thyroid cancer health disparities
(Impact Journals LLC) Thyroid cancer is one of the most prevalent endocrine cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2021 Category: International Medicine & Public Health Source Type: news
Targeted therapy pralsetinib safely effectively treats lung and thyroid cancers with RET alterations
(University of Texas M. D. Anderson Cancer Center) Results from the multi-cohort Phase I/II ARROW clinical trial, conducted by The University of Texas MD Anderson Cancer Center researchers, showed that a once-daily dose of pralsetinib, a highly selective RET inhibitor, was safe and effective in treating patients with advanced RET fusion-positive non-small cell lung cancer (NSCLC) and RET-altered thyroid cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 9, 2021 Category: Cancer & Oncology Source Type: news
Cancer symptoms: Expert uncovers five key signs of a growing thyroid tumour
ADVANCED technology is now capable of detecting cancer much sooner than ever before. All suspected thyroid cancers should be screened by an ultrasound, sometimes followed by a biopsy, and all overseen by an expert surgeon. (Source: Daily Express - Health)
Source: Daily Express - Health - June 5, 2021 Category: Consumer Health News Source Type: news
Study finds wide variation in costs of thyroid cancer care
There's a wide variation in cost and transparency of payer-negotiated prices for thyroid cancer care, according to a study published Friday in JAMA. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 4, 2021 Category: Consumer Health News Source Type: news
Wide variation in cost and transparency of payer-negotiated prices for thyroid cancer care
(Brigham and Women's Hospital) Since Jan. 1, 2021, hospitals in the US have been required by The Centers for Medicare and Medicaid Services (CMS) to provide pricing information online about items and services. A team of researchers from Brigham and Women's Hospital and Massachusetts Eye and Ear leveraged the newly available data to analyze price transparency and price variation for the treatment of thyroid cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2021 Category: International Medicine & Public Health Source Type: news
Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A comp...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
The LUCA device proves its readiness for a better thyroid cancer screening
(ICFO-The Institute of Photonic Sciences) The study recently published in Biomedical Optics Express and authored by members of the consortium reports on several study cases and clinical tests conducted to validate the accuracy and high quality of measurements achieved by the LUCA device. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 31, 2021 Category: Cancer & Oncology Source Type: news
Long-Term ERLEADA ® (apalutamide) Patient-Reported Outcomes Data in Metastatic Castration-Sensitive Prostate Cancer Demonstrate Maintenance of Health-Related Quality of Life for Patients
May 26, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced patient-reported outcomes (PRO) data from the pre-specified final analysis of the Phase 3 TITAN study in patients with metastatic castration-sensitive prostate cancer (mCSPC). The TITAN study previously demonstrated statistically significant improvement in overall survival (OS) after a median follow-up of 44 months in patients receiving ERLEADA® plus androgen deprivation therapy (ADT).1 The new PRO data showed that the addition of ERLEADA® to ADT maintained patients’ health-related quality of life (HRQoL) and ...
Source: Johnson and Johnson - May 26, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
AffyImmune Therapeutics' AIC100 Granted Fast Track Designation for Treating Thyroid Cancer
NATICK, Mass., May 17, 2021 -- (Healthcare Sales & Marketing Network) -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced today that the US Food and Drug... Biopharmaceuticals, Oncology, FDA AffyImmune Therapeutics, immunotherapy, Thyroid Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2021 Category: Pharmaceuticals Source Type: news
How Long Can You Live With Stage IV Thyroid Cancer?
Title: How Long Can You Live With Stage IV Thyroid Cancer?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 14, 2021 Category: Cancer & Oncology Source Type: news
Why this life sciences leader is stepping away from the CEO seat — and what she plans to do next
The CEO was a cofounder of the diagnostics company 14 years ago, starting with a thyroid cancer test that has helped more than 100,000 patients avoid surgeries. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 10, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news
Why this life sciences leader is stepping away from the CEO seat — and what she plans to do next
The CEO was a cofounder of the diagnostics company 14 years ago, starting with a thyroid cancer test that has helped more than 100,000 patients avoid surgeries. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 10, 2021 Category: American Health Authors: Ron Leuty Source Type: news
Are There Stages of Thyroid Cancer?
Title: Are There Stages of Thyroid Cancer?Category: Diseases and ConditionsCreated: 4/30/2021 12:00:00 AMLast Editorial Review: 4/30/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 30, 2021 Category: Cancer & Oncology Source Type: news
How Is Thyroid Cancer Detected?
Title: How Is Thyroid Cancer Detected?Category: Diseases and ConditionsCreated: 4/28/2021 12:00:00 AMLast Editorial Review: 4/28/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 28, 2021 Category: Cancer & Oncology Source Type: news
A New Frontier in Papillary Thyroid Cancer Treatment A New Frontier in Papillary Thyroid Cancer Treatment
What is the best course of treatment for small, low-risk papillary thyroid cancer? New developments have created opportunities to deliver care in a more individualized manner.American Thyroid Association (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 26, 2021 Category: Radiology Tags: Diabetes & Endocrinology Commentary Source Type: news
